中泰化學(002092.SZ):預計半年度虧損1.8億元至1.98億元
格隆匯7月14日丨中泰化學(002092.SZ)公佈,預計半年度虧損18,000萬元至19,800萬元,扣非虧損21,000萬元至23,000萬元。2025年上半年,公司主要原材料價格下降,主要產品聚氯乙烯(PVC)價格持續承壓走低。公司積極實施降本增效措施,推動氯鹼板塊盈利能力同比提升,紡織板塊經營業績略有改善,聯營企業虧損,公司整體仍未能扭虧爲盈,報告期內歸屬於母公司的淨利潤較上年同期減虧。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.